Forerun, Inc.: Series C $2M

Posted in I - Series C, Q - 2Q11, R - NORTH EAST, X - Bioinformatics, X - TeleMedicine, XX - MA

Foreun (Waltham, MA) a commercial-stage clinical electronic documentation and charting system for emergency care providers, closed a $2M Series C financing. Participants include Massachusetts Technology Development Corp.

Humedica, Inc.: Series B $20M

Posted in I - Series B, Q - 2Q11, R - NORTH EAST, X - Bioinformatics, X - TeleMedicine, XX - MA

Humedica (Boston, MA) a commercial-stage clinical trials informatics company, closed a $20M Series B financing. Participants have included Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners and Leerink Swann.

Ocimum Biosolutions, Inc.: Series C $8M

Posted in I - Series C, Q - 4Q10, R - MID ATLANTIC, X - Bioinformatics, XX - MD

Ocimum Biosolutions (Gaithersburg, MD) a commercial-stage integrated genomics company focused on sample data analysis and management, closed a $8M Series C financing. Participants have included International Finance Corp. and Kubera Partners.

DICOM Grid, Inc.: Series A $7.5M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - Bioinformatics, X - Imaging, X - TeleMedicine, XX - AZ

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

PathCentral, Inc.: Series B $10M

Posted in I - Series B, Q - 4Q10, R - WEST, X - Bioinformatics, XX - CA

PathCentral (Irvine, CA) a commercial-stage laboratory information system platform focused on the pathology practice, closed a $10M Series B financing. Participants include Okapi Venture Capital, Arboretum Ventures and Baird Venture Partners.

Zymeworks, Inc.: Series B $3.2M

Posted in I - Series B, Q - 2Q10, R - INTERNATIONAL, X - Bioinformatics

Zymeworks (Canada) a development-stage bioinformatics company focused on in silico optimization of protein-based therapeutics, closed a $3.2M Series B financing. Participants include CTI Life Sciences Fund.

Phreesia, Inc.: Series D $16M

Posted in I - Series D, Q - 2Q10, R - NORTH EAST, X - Bioinformatics, X - TeleMedicine, XX - NY

Phreesia (New York, NY) a commercial-stage developer of patient intake data, closed a $16M Series D financing. Participants include Ascension Health Ventures, BlueCross BlueShield Venture Partners, Sandbox Industries, Polaris Venture Partners, HLM Venture Partners and Long River Ventures.

Healthline Networks, Inc.: Series C $14M

Posted in I - Series C, Q - 2Q10, R - WEST, X - Bioinformatics, X - TeleMedicine, XX - CA

Healthline Networks (San Francisco, CA) a commercial-stage content provider of health information services, closed a $14M Series C financing. Participants include Investor Growth Capital, Peacock Equity Fund and Reed Elsevier Ventures.

MedVentive, Inc.: Series C $2.8M

Posted in I - Series C, Q - 2Q10, R - NORTH EAST, X - Bioinformatics, X - TeleMedicine, XX - MA

MedVentive (Waltham, MA) a commercial-stage electronic medical data company, closed a $2.8M Series C, bring the entire financing to $10M. Participants include HLM Venture Partners, Excel Venture Management, Clarian Health Ventures, Core Capital Partners and Long River Ventures.

Allocade, Inc.: Series C $5M

Posted in I - Series C, Q - 1Q10, R - WEST, X - Bioinformatics, X - TeleMedicine

Allocade (Mountain View, CA) a commercial-stage healthcare information technology company focused on patient flow logistics software for hospitals, closed a $5M Sereis C financing. Participants include VantagePoint Venture Partners.

PatientSafe Solutions, Inc.: Series B $30M

Posted in I - Series B, Q - 1Q10, R - WEST, X - Bioinformatics, X - TeleMedicine, XX - CA

PatientSafe Solutions (San Diego, CA) a medical technology company focused on point-of-care defense against preventable patient errors for hospital acquired infections, medication errors, and patient falls, closed a $30M Series B financing. Participants include TPG Growth, Camden Partners, Psilos, Menlo Ventures, American River Ventures, Integral Capital Partners and Shea Ventures.

Centice Corp.: Series C $6.1M

Posted in I - Series C, Q - 4Q09, R - SOUTH EAST, X - Bioinformatics, XX - NC

Centice (Morrisville, NC) developer of a pharmaceutical verification device to improve accuracy of dispensed medications, closed a $6.1M Series C financing. Participants include Fulcrum Financial Group, The Aurora Funds, S-Group Direct Investments, Innovation Ventures and Novak Biddle Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Metabolon, Inc.: Series C $6M

Posted in I - Series C, Q - 4Q09, R - SOUTH EAST, X - Bioinformatics, X - Biomarker, X - Device (Diagnostic), XX - NC

Metabolon (Durham, NC) a metabolomics services and informatics company focused on detection of small molecule biomarkers, closed a $6M Series C financing, bringing the entire financing round to $12.3M. Participants include Syngenta Ventures, Fletcher Spaght Ventures, Sevin Rosen Funds, Aurora Funds, Harris and Harris Group, Fulcrum Financial Partners and Alexandria Equities.

« Previous Entries

to top of page...